GTS Securities’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-381,700
Closed -$1.08M – 1781
2024
Q3
$1.08M Buy
381,700
+260,200
+214% +$596K ﹤0.01% 2098
2024
Q2
$149K Buy
121,500
+47,900
+65% +$43K ﹤0.01% 3531
2024
Q1
$58.4K Sell
73,600
-48,700
-40% -$44.3K ﹤0.01% 3611
2023
Q4
$116K Sell
122,300
-52,300
-30% -$51.4K ﹤0.01% 3718
2023
Q3
$189K Buy
+174,600
New +$208K ﹤0.01% 3437

Other funds holding CLOV

GTS Securities's CLOV Position: Q2 2026 in Review

GTS Securities opened a new position in Clover Health Investments (CLOV) in Q2 2026: 13,664 shares worth $71.6K. The stake represents ﹤0.01% of the portfolio and ranks #1269 among its holdings. This is a return to the name: GTS Securities previously reported a position in CLOV as recently as Q4 2025.

GTS Securities first reported a position in CLOV in Q1 2024 and has held it in 4 quarters since. The position peaked at $89.8K in Q2 2024. 227 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • GTS Securities held 13,664 shares of Clover Health Investments worth $71.6K as of Q2 2026.
  • Clover Health Investments was a new GTS Securities position in Q2 2026.
  • Clover Health Investments made up ﹤0.01% of GTS Securities's portfolio in Q2 2026, its #1269 holding.
  • GTS Securities first reported a position in Clover Health Investments in Q1 2024 and has held it in 4 quarters since.
  • GTS Securities's Clover Health Investments position peaked at $89.8K in Q2 2024.
  • 227 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on GTS Securities's 13F filing for Q2 2026, filed 14 Aug 2026.